Evidence map›Paper›PMID 30842981›Full record

ArticleACS omega2019

Solution Structure of a

Jonathan Dickerhoff, Buket Onel, Luying Chen, Yuwei Chen, Danzhou Yang

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 41 citations in OpenAlex.

  1. Structural basis for nucleolin recognition ofScience (New York, N.Y.) · 2025
    Article
  2. Article
  3. Article
  4. Research Progress on Pyroptosis in Hematological Malignancies.Current treatment options in oncology · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Insights into the binding mode of AS1411 aptamer to nucleolin.Frontiers in molecular biosciences · 2022
    Article
  12. Article
  13. Article
  14. Thermodynamic Stability of G-Quadruplexes: Impact of Sequence and Environment.Chembiochem : a European journal of chemical biology · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jonathan DickerhoffCollege of Pharmacy, Medicinal Chemistry and Molecular Pharmacology, Purdue University, 575 W Stadium Avenue, West Lafayette, Indiana 47907, United States.
Buket OnelCollege of Pharmacy, Medicinal Chemistry and Molecular Pharmacology, Purdue University, 575 W Stadium Avenue, West Lafayette, Indiana 47907, United States.
Luying ChenCollege of Pharmacy, Medicinal Chemistry and Molecular Pharmacology, Purdue University, 575 W Stadium Avenue, West Lafayette, Indiana 47907, United States.
Yuwei ChenDepartment of Chemistry and Biochemistry, College of Science, University of Arizona, 1306 E. University Blvd, Tucson, Arizona 85721, United States.
Danzhou YangCollege of Pharmacy, Medicinal Chemistry and Molecular Pharmacology, Purdue University, 575 W Stadium Avenue, West Lafayette, Indiana 47907, United States.
Purdue University West Lafayette · USUniversity of Arizona · US

Funding

Transgenic Mouse Core Facility Shared Resource (TMCF-SR)P30CA023168 · NCI · PURDUE UNIVERSITY WEST LAFAYETTE · PI Andrea L Kasinski · 1985 to 2026
$43.4M
Targeting MYC promoter G-quadruplex for MYC inhibition by IndenoisoquinolinesR01CA177585 · NCI · UNIVERSITY OF ARIZONA · PI SINTIM, HERMAN O, YANG, DANZHOU · 2014 to 2025
$4.0M
NCI NIH HHS P30 CA023168NCI NIH HHS R01 CA177585
6 · The paper itself

Abstract

The important

Identifiers

PMID30842981
PMCPMC6396123
OpenAlexW2913408997

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.